Pacific Biosciences Of California | PACB - Cash And Equivalent

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $56.47M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Illumina USD 1.42B 368M Dec/2025
Myriad Genetics USD 145.4M 71M Sep/2025
Pacific Biosciences Of California USD 56.47M 1.66M Sep/2025
Quidel USD 169.8M 71.7M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Standard Biotools USD 129.42M 29.2M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Waters USD 587.83M 128.71M Dec/2025